Results 91 to 100 of about 21,617 (174)

Editorial. [PDF]

Gesundheitswesen, 2022
Nießen J, Bruns-Philipps E, Stark K.
europepmc   +1 more source

Whole-Exome Sequencing, Mutational Signature Analysis, and Outcome in Multiple Myeloma-A Pilot Study. [PDF]

Int J Mol Sci
Oelschläger L, Künstner A, Frey F, Leitner T, Leypoldt L, Reimer N, Gebauer N, Bastian L, Weisel K, Sailer VW, Röcken C, Klapper W, Konukiewitz B, Murga Penas EM, Forster M, Schub N, Ahmed HMM, Kirfel J, von Bubnoff NCC, Busch H, Khandanpour C.   +20 more
europepmc   +1 more source

Integrated Climate Solutions: From Subsidies to Finance with Green Banks [PDF]

, 2016
Andrews, Jennifer, Ashcraft, Catherine, Herndon, Henry, Kelly, Tom, Large, Sarah, Queen, Irene, Wake, Cameron P.   +6 more
core   +1 more source

[Guardrails instead of barriers]. [PDF]

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, 2023
Weber S, Kuhn J.
europepmc   +1 more source

Serum antigen tests for the diagnosis of invasive aspergillosis: a retrospective comparison of five <i>Aspergillus</i> antigen assays and one beta-D-glucan assay. [PDF]

J Clin Microbiol
Schub T, Klugherz I, Wagener J, Prattes J, Hoenigl M, Suerbaum S, Held J, Dichtl K.   +7 more
europepmc   +1 more source

Extraartikuläre Rheuma-Manifestationen rücken in den Fokus. [PDF]

Rheuma Plus, 2023
europepmc   +1 more source

Visualization of Keratopathy Associated With the Antibody-Drug Conjugate Belantamab Mafodotin Using Infrared Imaging in Patients With Multiple Myeloma. [PDF]

Cornea
Gallin V, Nölle B, Schub N, Roider J.
europepmc   +1 more source

MSmonitor-plus program and video calling care (MPVC) for multidisciplinary care and self-management in multiple sclerosis: study protocol of a single-center randomized, parallel-group, open label, non-inferiority trial. [PDF]

BMC Neurol, 2022
Hoving M, Jongen PJ, Evers SMAA, Edens MA, Zeinstra EMPE.   +4 more
europepmc   +1 more source

"Pisa-Schub"

netbib, 2003
openaire   +2 more sources

Development and Validation of a Prediction Model of Outcome After B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory Multiple Myeloma. [PDF]

J Clin Oncol
Gagelmann N, Dima D, Merz M, Hashmi H, Ahmed N, Tovar N, Oliver-Caldés A, Stölzel F, Rathje K, Fischer L, Born P, Schäfer L, Albici AM, Schub N, Kfir-Erenfeld S, Assayag M, Asherie N, Wulf GG, Kharboutli S, Müller F, Shune L, Davis JA, Anwer F, Vucinic V, Platzbecker U, Ayuk F, Kröger N, Khouri J, Gurnari C, McGuirk J, Stepensky P, Abdallah AO, Fernández de Larrea C.   +32 more
europepmc   +1 more source